Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.

Publication ,  Journal Article
Toh, S; Baker, MA; Brown, JS; Kornegay, C; Platt, R; Mini-Sentinel Investigators,
Published in: Jama Intern Med
May 13, 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Jama Intern Med

DOI

EISSN

2168-6114

Publication Date

May 13, 2013

Volume

173

Issue

9

Start / End Page

817 / 819

Location

United States

Related Subject Headings

  • Varenicline
  • United States Food and Drug Administration
  • United States
  • Tobacco Use Disorder
  • Smoking Cessation
  • Sentinel Surveillance
  • Risk Factors
  • Risk Assessment
  • Quinoxalines
  • Product Surveillance, Postmarketing
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Toh, S., Baker, M. A., Brown, J. S., Kornegay, C., Platt, R., & Mini-Sentinel Investigators, . (2013). Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Jama Intern Med, 173(9), 817–819. https://doi.org/10.1001/jamainternmed.2013.3004
Toh, Sengwee, Meghan A. Baker, Jeffrey S. Brown, Cynthia Kornegay, Richard Platt, and Richard Mini-Sentinel Investigators. “Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.Jama Intern Med 173, no. 9 (May 13, 2013): 817–19. https://doi.org/10.1001/jamainternmed.2013.3004.
Toh S, Baker MA, Brown JS, Kornegay C, Platt R, Mini-Sentinel Investigators. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Jama Intern Med. 2013 May 13;173(9):817–9.
Toh, Sengwee, et al. “Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.Jama Intern Med, vol. 173, no. 9, May 2013, pp. 817–19. Pubmed, doi:10.1001/jamainternmed.2013.3004.
Toh S, Baker MA, Brown JS, Kornegay C, Platt R, Mini-Sentinel Investigators. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Jama Intern Med. 2013 May 13;173(9):817–819.

Published In

Jama Intern Med

DOI

EISSN

2168-6114

Publication Date

May 13, 2013

Volume

173

Issue

9

Start / End Page

817 / 819

Location

United States

Related Subject Headings

  • Varenicline
  • United States Food and Drug Administration
  • United States
  • Tobacco Use Disorder
  • Smoking Cessation
  • Sentinel Surveillance
  • Risk Factors
  • Risk Assessment
  • Quinoxalines
  • Product Surveillance, Postmarketing